Suggestions
Scott Morenstein
Managing Director, Head of Life Sciences Public and Private Investing at CAM Capital
Scott Morenstein is an accomplished professional with a diverse background spanning both biotechnology and investment banking.
He holds a BA in Biological Basis of Behavior from the University of Pennsylvania and completed his MBA at the prestigious Harvard Business School.
Scott has held various key positions within notable organizations, notably serving as Managing Director at CAM Capital.
His experience includes serving on the Board of Directors at several biotechnology companies like Primmune Therapeutics, Antios Therapeutics, and Molecular Templates.
Moreover, Scott has a strong background in investment banking, having worked at Lehman Brothers and Seaview Securities.
Throughout his career, Scott Morenstein has showcased his expertise in the biotechnology and finance sectors, making him a well-rounded professional with valuable insights to offer.
His contributions to organizations such as Valence Life Sciences, Gemin X Pharmaceuticals, and Caxton Advantage Venture Partners have been instrumental in driving growth and success in the industry.
